Table 1 Data variables and source for cost regarding screening, management and treatment of prostate cancer
Data | Data source | Price source |
|---|---|---|
Estimated number of cases in 2018 = 90 | Swaziland National Cancer Unit, Eswatini Prostate cancer cases in 2018 | N/A |
Screening | ||
Consultation fee | Mbabane Clinic | Private hospital |
Prostate Specific Antigen (PSA) | Eswatini Health Laboratory Services | Private hospital |
Digital rectal examination (DRE) | Interview with expert | Private hospital |
Diagnosis | ||
TRUS guided Biopsy | Mbabane Clinic | Private hospital |
Computed Tomography (CT scan) | Mbabane Clinic | Private hospital |
MRI scan | Phalala fund | Private hospital |
X-ray | Mbabane Clinic | Private hospital |
Bone scan | Mbabane Clinic | Private hospital |
Intervention/Treatment | ||
Watchful waiting (WW) | Interview with expert | Private hospital |
Surgery | Mbabane clinic | Private hospital |
Radiotherapy | Phalala Fund based on SA hospitals fees | Private hospital |
Chemotherapy | Phalala Fund based on SA hospitals fees | Private hospital |
Androgen deprivation | Phalala Fund based on SA hospitals fees | Market price |
Hospitalization (local) | Phalala Fund based on SA hospitals fees | Private hospital |
Other direct costs | ||
Transport and lodging costs in South Africa | Phalala Fund based on SA hospitals fees | Market price |
Follow-up care (Year 1 following completion of treatment) Follow-up involves PSA testing, symptomology and clinical examination for metastatic cancer twice in a year | Based on reported prevalence | Private hospital |